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Abstract
Malnutrition is a highly prevalent and under recognized condition in developing 
countries of South Asia. The presence of malnutrition causes a severe impact on 
patients with liver cirrhosis. The etiology of cirrhosis differs in the South Asian 
region compared to the West, with hepatitis B and C still being the leading causes 
and the prevalence of nonalcoholic fatty liver disease increasing over time. 
Comorbid malnutrition worsens outcomes for cirrhosis patients. Urgent attention 
to address malnutrition is needed to improve patient outcomes. The etiology and 
pathophysiology of malnutrition in liver diseases is multifactorial, as reduction in 
liver function affects both macronutrients and micronutrients. A need for nutri-
tional status assessment for liver disease patients exists in all parts of the world. 
There are many widely studied tools in use to perform a thorough nutritional 
assessment, of which some tools are low cost and do not require extensive 
training. These tools can be studied and evaluated for use in the resource limited 
setting of a country like Pakistan. Treatment guidelines for proper nutrition 
maintenance in chronic liver disease exist for all parts of the world, but the 
knowledge and practice of nutritional counseling in Pakistan is poor, both amon-
gst patients and physicians. Emphasis on assessment for nutritional status at the 
initial visit with recording of vital signs is needed. Simultaneously, treating phy-
sicians need to be made aware of the misconceptions surrounding nutritional 
restrictions in cirrhosis so that patient education is done correctly based on proper 
scientific evidence.
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Core Tip: Malnutrition in liver cirrhosis is a serious problem in South Asia where the 
etiology differs from the Western population. As malnutrition is generally highly 
prevalent in the region, it causes an impact on patients with liver cirrhosis. Urgent 
attention to address malnutrition is needed to improve patient outcomes. Emphasis on 
assessment for nutritional status at the initial visit with recording of vital signs is also 
needed. Simultaneously, treating physicians need to be made aware of the miscon-
ceptions surrounding nutritional restrictions in cirrhosis so that patient education is 
done correctly based on proper scientific evidence.
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Malnutrition (undernutrition) is defined as an insufficient intake or assimilation of 
nutrients essential for development and prevention of disease[1]. Malnutrition pre-
sents as a common complication of end-stage liver failure (cirrhosis), which is charac-
terized by mass systemic complications such as refractory ascites, spontaneous 
bacterial peritonitis, hepatorenal syndrome and variceal hemorrhage[2]. Due to the 
deterioration of health that cirrhosis causes, approximately a million people die from 
cirrhosis globally, making it a significant disease burden to be addressed.
Several studies have evaluated nutritional status in patients with liver cirrhosis of 
different etiologies and varying degrees of liver insufficiency[3,4] leading to a con-
sensus that malnutrition is recognizable in all forms of cirrhosis[5] with the prevalence 
of malnutrition in cirrhosis having been estimated to range from 65%-100%[6,7]. Thus, 
malnutrition becomes an important prognostic indicator of clinical outcomes, which 
include survival rate, the length of hospital stay, post-transplantation morbidity and 
quality of life in patients with cirrhosis[8], particularly in patients with severe cirrhosis 
and alcoholic cirrhosis where malnutrition is more likely to be present[9]. While 
malnutrition remains potentially modifiable, it has been observed starting from the 
initial stages of liver disease that results in an almost direct relationship between the 
liver disease severity and the extent of malnutrition, with malnutrition becoming 
easier to detect in severe cirrhosis[10].
The causes of malnutrition in liver disease are complex and multifactorial due to the 
liver forming a fundamental part of the body’s metabolism. It results from impaired 
dietary intake due to the malfunctioning liver, chronic inflammation and subsequently 
the altered macronutrient and micronutrient metabolism. Low patient activity is also 
attributed to it[7,11]. Additionally, anorexia, gastroparesis, nausea, increased leptin 
levels, encephalopathy and gastritis are found to be contributors of malnutrition. 
Ascites, frequent paracentesis, some drugs such as diuretics and lactulose, a sodium-
restricted diet and alcohol consumption (decreases appetite) can also result in me-
tabolic malfunctioning and thus contribute to a reduction in dietary intake, which 
leads to malnutrition in liver disease[12,13]. The deficiency of biliary salts due to liver 
malfunction and decreased assimilation of nutrients, abnormal motility of the di-
gestive tract and an increased bacterial growth may subsequently lead to an impaired 
uptake and metabolism of nutrients, resulting in malnutrition[14]. Portal hypertension 
leads to an increased permeability of the intestinal mucosa, thereby causing an 
increased loss of proteins that may be similarly noted in cases of bleeds caused by 
varices or ulcers[15]. A poor nutritional status then poses significant consequences for 
postoperative complications among transplant candidates as well because this is an 
important prognosticator for mortality and morbidity among chronic liver disease 
(CLD) patients[9]. Subsequently, malnutrition itself becomes an independent predictor 
of mortality in patients with CLD.
The resultant malnutrition comprises of both macro and micronutrient deficiencies. 
The macronutrients (being proteins, carbohydrates and fats) have their metabolism 
affected[16], while protein deficiency makes patients more susceptible to hepato-
cellular disease, in particular. On the micronutrient level, patients with a history of 
cholestatic liver disease are more liable to have an insufficient calorie intake with a 
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higher risk of vitamin deficiencies. Detecting micro or macronutrient deficiencies at an 
earlier stage is crucial so that nutritional supplementation can be initiated in a timely 
manner, which has been proven to decrease the risk of infection and in-hospital 
mortality while enhancing liver function. Therefore, it has been recommended that all 
patients with CLD should be screened to have an early identification of those at risk of 
complications so that relevant interventions can be started[17].
In this article, we will be reviewing the prevalence, underlying mechanism and 
factors associated with malnutrition and the impact of malnutrition in cirrhosis in the 
setting of a developing country. This will pave the way for increased awareness 
regarding malnutrition in cirrhosis and its consequences to subsequently treat the 
patients accordingly for better outcomes.
MALNUTRITION IN SOUTH ASIA
While about 2 billion people in the world are suffering from various forms of mal-
nutrition[18], the prevalence of malnutrition due to cirrhosis is estimated to range 
from 65%-100% globally[6,7]. In South Asia particularly, malnutrition is rampant with 
a high prevalence of low adult body mass index (BMI) (23.4% in men and 24.0% in 
women in 2014)[19]. In this region, Pakistan in particular has 45.3 million people (28 
percent of the population) being victims of food insecurity according to the National 
Nutrition Survey Report 2011[20]. The global nutrition report 2020 has studied the 
progress of attaining 10 global nutrition targets of 2025 in 194 countries (which include 
anemia, low birth weight, exclusive breastfeeding, childhood stunting, childhood 
wasting, childhood overweight, adult obesity and adult diabetes, salt intake and raised 
blood pressure). Progress is not assessed at the country level for salt intake and blood 
pressure. Data collected for 8 of the 10 targets shows that Pakistan is on track for only 
2 targets out of 8. In Pakistan, more than half of children grow up stunted or wasted. 
Pakistan is recognizing this issue as important, as is evident by it being 1 of the 25 
countries to have revisited their nutrition budget, which has resulted in allocating 
increased funds towards nutrition thrice since 2015. Of this, the highest increase is 
towards nutrition sensitive allocation of social protection. The report highlights the 
importance for subnational level of financing for nutrition in areas like Balochistan in 
Pakistan and Rajhasthan in India. Pakistan and India comprise two of the three 
countries with the highest number of stunted children with 10.7 million stunted 
children in Pakistan and 25.5 million in India. This data reflects the severity of 
malnutrition in the region and can be extrapolated to the adult population of the South 
Asian countries[21].
LIVER DISEASES IN SOUTH ASIA
While most of the burden of liver cirrhosis in western countries is nonalcoholic fatty 
liver disease, most of it for South Asian countries is related to hepatitis B and C. 
However, increasing prevalence of nonalcoholic fatty liver disease is being seen in the 
South Asian population as well[22]. A survey conducted in 2015 showed the incidence 
of cirrhosis in South Asia to be 21.39% overall with 6.98% being hepatitis B virus 
related, 4.87% hepatitis C virus related, 4.84% alcohol related and 4.69% due to other 
etiologies[23]. The incidence of cirrhosis is estimated to be 23.6 per 100000 in Southeast 
Asia in 2017[24,25]. A study comparing liver resection patients between the East and 
the West of the world showed that patients from the East had worse Child Pugh scores 
and had a more advanced stage of cancer than the West[26]. A multicenter study from 
India revealed that at least a third of the patients presenting with CLD present at a 
very advanced stage of decompensated cirrhosis[27].
ETIOLOGY AND PATHOPHYSIOLOGY
The flowcharts in Figures 1 and 2 describe the pathophysiology of malnutrition as a 
consequence of cirrhosis and the multiple pathways that lead to it[28].
Metabolic changes occurring in CLD
Multiple changes in nutrient metabolism are observed in cirrhosis, which subse-
quently contributes to malnutrition. Around 14% to 40% of patients with cirrhosis 
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Figure 1 Pathophysiology of malnutrition as a consequence of cirrhosis and the multiple pathways that lead to it. AAA: Aromatic amino acids; 
BCAA: Branched chain amino acids.
Figure 2 Pathophysiology of malnutrition as a consequence of cirrhosis and the multiple pathways that lead to it. GI: Gastrointestinal; NASH: 
Nonalcoholic steatohepatitis; TNF: Tumor necrosis factor.
have been diagnosed with type 2 diabetes mellitus due to glucose intolerance or end 
stream resistance to insulin seen in an estimated 70% of cirrhotic patients[29]. It has 
also been observed that the levels of hepatic and muscle glycogen are decreased, 
leading to a reduction in the availability of glucose as an energy substrate, with the 
body switching to the consumption of fats and proteins as alternative energy sources
[30].
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Regarding the rest energy expenditure (REE), a measure of resting metabolic rate 
and defined as the energy expended to sustain homeostasis at rest, conflicting results 
have been reported. Up to 34% of patients have been claimed to have a REE out of 
range by being about 120% higher, while some results show most of the patients with 
a REE within range[9,31,32]. Further measuring the calorie consumption, a cross-
sectional study of 473 patients with cirrhosis found that 34% had hypermetabolism, 
measured by indirect calorimetry. The increase in REE was associated with lean body 
mass and an increase in beta-adrenergic activity but not with the severity or type of 
liver disease. Further studies have demonstrated that hypermetabolism can persist at 
least 1 year after liver transplant and correlates with a reduction in survival, also 
indicating prognosis[33]. Ascites can also contribute to an increase in REE due to 
which its removal results in a significant reduction in the REE when measured by 
indirect calorimetry. The mechanism underlying this observation is unclear[34].
The muscle plays a significant role in metabolism particularly of amino acids (AA). 
It also constitutes an important site for glutamine synthesis and gluconeogenesis. It 
should be noted that gluconeogenesis plays a direct role in the destruction of muscle 
tissue, with the body deriving protein substrates from the muscle for metabolism. This 
destruction of muscle subsequently causes a decrease in the synthesis of proteins and 
in its break down, also causing these patients to become protein deficient. Therefore, 
the most common complication of cirrhosis is a presentation of sarcopenia, observable 
in almost 60% of patients[35,36]. The ratio of branched chain AA (BCAA) to aromatic 
AA declines in CLD. A similar effect is seen in sepsis and major trauma. It is due to 
this change that malnourished individuals often develop hepatic encephalopathy 
(HE). This has established sarcopenia as an important risk factor for HE[36,37]. Further 
contributing to the increase in the consumption of AA by the muscles is the factor of 
any overnight fast that promotes an increase in ketogenesis and gluconeogenesis, even 
with lipids representing 75% of the calories expended during such a period. Healthy 
subjects after 3 d of fasting may also have a similar effect, but it occurs much slower 
when compared with cirrhotic patients[38].
There is an overall loss of protein from reduced synthesis of urea and hepatic 
proteins, reduced intestinal protein absorption and increased urinary nitrogen excre-
tion[39]. The deficiency of AA and thus proteins gives rise to specifically a protein-
calorie malnutrition (PCM). Each stage of CLD is affected by PCM with PCM being 
present in 65%-90% of patients with advanced disease. PCM also detrimentally causes 
systemic complications. There is an increased risk of HE and hepatorenal syndrome, 
while esophageal varices may often be seen as well. There is also a reduced regene-
ration capacity of the liver with a declining trend of liver function and an increased 
risk of surgical morbidity as well as mortality, all due to the protein and AA deficiency 
causing subsequent metabolic dysfunction[40,41].
Peripheral insulin resistance and β-cell dysfunction due to abnormal cell signaling 
pathways in cirrhotic patients leads to pancreatic dysfunction, giving rise to hepato-
genous diabetes, steatorrhea and overall pancreatic disease[42,43]. The improper 
carbohydrate metabolism preferentially causes lipids to be oxidized instead for ener-
gy. This increases lipolysis and fatty acid oxidation, while an increase in the produc-
tion of ketones may also occur. Therefore, reduced levels of plasma triglycerides, 
phospholipids, cholesterol, apoproteins and polyunsaturated fatty acids occurs in 
cirrhotic patients over time. These decreasing levels can be correlated with the severity 
of the liver disease, becoming an independent predictor of mortality in alcoholic 
cirrhosis. The respiratory quotient is also lowered when compared to non-diseased 
patients, also pointing towards poorer patient outcomes[44,45].
Deficiency of micronutrients
Micronutrient deficiency is common in cirrhosis, most observed in alcoholic disease. 
The most common deficiency seen is that of group B vitamins. Deficient levels of 
micronutrients are explained mainly by a decreased oral intake, malabsorption and 
declining hepatic reserves[46]. Fat-soluble vitamins such as Vitamin A, D, E and K 
have been seen to be deficient in alcoholic disease, along with steatorrhea, cholestasis 
and bile salt deficiency, negatively impacting patient outcomes[12,47]. Thiamine 
deficiency is also often found particularly in alcoholic disease as well as other forms of 
cirrhosis. Intake of alcohol causes a decline in the intestinal absorption and metabol-
ization of thiamine. This increases the risk of developing Wernicke encephalopathy 
and Korsakoff dementia due to a decline in neurotransmitter synthesis, nucleic acid 
synthesis and synthesis of steroids and fatty acids[48]. Decreasing liver reserves cause 
a vitamin B12 and folic acid deficiency. While the levels of vitamin B12 in the serum 
may be increased, decreased tissue levels are observed. Anemia, glossitis and neuro-
logical symptoms may subsequently occur[12,49].
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Retinol deficiency also occurs in cirrhosis and is related with decreased absorption 
and impaired hepatic mobilization due to hepatic stellate cell injury. This may result in 
dermatitis, night blindness, dyslipidemia or photophobia and increase the risk of 
hepatocellular carcinoma and other neoplastic disorders[50-52]. Vitamin A supple-
mentation should be administered carefully because its excess causes hepatotoxicity
[53]. Vitamin K deficiency results from declining hepatic reserves, increasing the risk 
of bleeding; while vitamin D deficiency can be caused from a reduced ingestion and 
absorption. Absorption is impaired in underexposure to ultraviolet light as well as in 
cholestatic disease or portal hypertension enteropathy[54]. Patients with abnormal 
liver functioning have deficient vitamin D levels as hydroxylation is required to 
synthesis calcidiol. A significant part of the liver loses function before calcidiol 
production is seen to be decreased. It is due to this that patient presentation with 
biochemical or histological evidence of osteomalacia is rare, unless a vitamin D defi-
ciency is present concomitantly[55,56]. Therefore, decreasing vitamin D levels directly 
increase the risk of patient mortality where CLD is also present. It also contributes to 
failure of treatment of liver diseases especially in patients being treated for hepatitis C
[57].
Other deficiencies present in patients with alcoholic and nonalcoholic liver disease 
include that of zinc and selenium. Their supplementation has improved CLD out-
comes[58]. Zinc deficiency is caused by a reduction in intake and systemic assimila-
tion. Treatment with diuretics is also a contributor. The levels of ammonia rise in the 
circulation, which causes dysregulation of hepatocyte functioning and an increased 
risk of HE. Anorexia can also be caused with this deficiency, along with the dys-
function of the immune system[38,59]. Magnesium deficiency is also noted with alco-
hol consumption causing not just folate deficiency but also contributing to decreasing 
magnesium levels. Magnesium deficiency was observed in 30% to 80% of alcoholics. 
Dysfunctional magnesium transport and homeostasis in vital organs such as the brain, 
skeletal muscle, heart and liver can result due to alcohol intake. Often magnesuria can 
also occur[60]. The subsequent magnesium deficiency can cause dysgeusia and con-
tribute to minimal HE, which further decreases the patients’ intakes and worsens 
outcomes. Clinical improvement is therefore noted with magnesium supplementation
[54]. Table 1 summarizes the effects of each micronutrient deficiency caused by liver 
disease.
NUTRITIONAL ASSESSMENT IN CLD
A nutritional assessment determines both the macro and micronutrient state of a 
patient. It is necessary to identify nutritional risks that affect morbidity and mortality 
and helps develop a targeted therapy to benefit the patient.
Malnutrition is more evident in decompensated compared to compensated cirr-
hosis. The 2019 European Association for the Study of the Liver guidelines recommend 
a screening of all advanced CLD patients for malnutrition (undernutrition), as it is a 
recognized complication of liver cirrhosis. Criteria for patients at high risk of malnu-
trition are: (1) a BMI < 18.5 kg/m2; and (2) advanced decompensated cirrhosis (Child-
Pugh C patients)[57].
Thus, an assessment and diagnosis of malnutrition should be done thoroughly 
starting with a detailed history and physical examination. A thorough history can help 
identify poor intake, eating habits, loss of appetite, weight changes and any episodes 
of diarrhea and malabsorption as a potential source of malnutrition in a patient. 
Calculation of the patient’s BMI and determination of the Child Pugh Score for 
severity of disease is also important with the history, as a direct correlation exists 
between severity of disease and malnutrition. A physical examination also provides 
insight about any macro and micronutrient deficiencies. Specific physical findings, 
such as pallor in iron deficiency anemia, are very important to observe and record[9,
61].
Skeletal muscle loss (sarcopenia) has been established as the most common 
complication of cirrhosis[59]. It is associated with severe outcomes in patients with 
liver cirrhosis and is considered useful for the global assessment of patients with CLD, 
therefore a physical examination for it is important[62]. A multitude of different 
standardized nutritional status assessment tools also exist that can be used for exa-
mination.
Subjective global assessment scale
This includes components of history and physical exam and does not rely on any lab 
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Table 1 Effects of each micronutrient deficiency caused by liver disease
Micronutrient Effect caused by deficiency in liver disease
Vitamin A Dermatitis, night blindness, dyslipidemia, photophobia, increased risk of neoplasia
Vitamin B1 Wernicke encephalopathy and Korsakoff dementia
Vitamin B9 Dementia
Vitamin B12 Anemia, glossitis and neurological symptoms (numbness, muscle weakness and ataxia)
Vitamin D Rare osteomalacia, increased risk of mortality
Vitamin E Reduced antioxidation
Vitamin K Increased risk of bleeding
Zinc Hepatocyte dysfunction, increased risk of hepatic encephalopathy
Magnesium Dysgeusia, increased risk of hepatic encephalopathy
parameters[63]. Weight changes, dietary intake changes, presence of gastrointestinal 
symptoms, functional capacity and the metabolic demand associated with the disease 
state are the historical components, while the physical examination components 
include the presence of edema, ascites, muscle wasting and subcutaneous fat loss. The 
scale classifies patients from well-nourished to severely malnourished[64]. However, 
this scale underestimates the presence of sarcopenia and is not a good outcomes 
predictor[65].
Royal free hospital subjective global assessment
This is a modified version of the subjective global assessment and includes some 
objective variables as well like anthropometry and gender of the patient[66].
Assessment of sarcopenia
Computed tomography scan: Computed tomography scan can be utilized to calculate 
the cross-sectional area of muscles at the L3 vertebral level. The psoas, paraspinal and 
abdominal wall muscles are used to calculate their skeletal muscle area. The skeletal 
muscle index is calculated by dividing the skeletal muscle area by the patient height. A 
value of the skeletal muscle index less than 50 for men and less than 39 for women is 
considered to meet the criteria for sarcopenia. Computed tomography scan is an 
expensive tool and not routinely performed but if done for screening of hepatocellular 
carcinoma, evaluation for liver transplant or vascular shunt can be utilized for 
assessment of sarcopenia and calculation of the skeletal muscle index[67,68].
Anthropometry: Anthropometry as a screening tool for nutritional assessment can 
prove to be important in resource limited settings. The easiest and least technically 
challenging is the measure of the BMI using anthropometric measurements. However, 
the use of BMI as a nutritional assessment tool in patients with advanced liver disease 
is limited as patients are often in a volume overload state, which affects their body 
weight[9]. A corrected BMI can be calculated instead after paracentesis of ascitic fluid 
or by using dry body weight[65,69]. Mid arm muscle circumference is an important 
alternative measurement and is not reflective of the overall body volume status. Mid 
arm muscle circumference shows good correlation with body cell mass measurement, 
which is a proven marker for PCM in CLD patients. Mid arm muscle circumference is 
related to mortality risk in CLD patients and hence holds prognostic value as well[70]. 
Skin fold thickness measurement can also be used as a nutritional status assessment 
tool. Thickness can be measured at the triceps, biceps, subscapular and supra-iliac 
areas and is representative of fat reserve. It recognizes malnutrition earlier than the 
BMI[61].
Dual-energy X-ray absorptiometry scan: Dual-energy X-ray absorptiometry is a 
radiological modality that is used to measure bone mass, fat mass and fat free mass, 
which is representative of lean muscle mass[71]. Its use is limited in cirrhotic patients 
as fat free mass can also include water mass.
Bioelectrical impedance analysis
Bioelectrical impedance analysis is a low cost, easy to administer screening tool. 
Alternating current is applied using two electrodes, and the impedance recorded. This 
Siddiqui ATS et al. Malnutrition and liver disease
WJG https://www.wjgnet.com 4992 August 14, 2021 Volume 27 Issue 30
can be performed at the bedside. Bioelectrical impedance analysis is used to estimate 
total body water, fat mass and hence fat free mass. However, bioelectrical impedance 
analysis was shown to underestimate malnutrition status as compared to the PCM 
score in a study from Pakistan. PCM score is thus calculated using anthropometric 
measurements and some lab parameters[40].
Liver specific tools
A few specific nutrition screening tools have been developed for liver disease patients 
and these include the Royal Free Hospital-Nutrition Prioritizing Tool and the Liver 
Disease Undernutrition Screening Tool. The Royal Free Hospital-Nutrition Prioritizing 
Tool score includes components involving weight loss, volume overload, BMI and 
reduced oral intake. Patients are then classified as being at low, moderate or high risk 
for malnutrition[72]. The Liver Disease Undernutrition Screening Tool includes 
components of oral intake, weight loss, loss of subcutaneous fat or muscle mass, 
volume overload and functional status[73,74]. These tools have not been studied in 
detail in the South Asian Population.
Dietary assessment
A dietary interview with the patient provides important insight to the patient’s 
nutritional status. It recognizes barriers to nutritional intake and any deficiencies that 
need to be addressed. A thorough evaluation includes number of meals eaten, time 
between each meal, protein and fluid intake and total calories consumed as well as any 
nausea, vomiting, diarrhea or constipation. A thorough evaluation takes time and 
requires trained staff. Additionally, patient factors such as poor recall and lack of 
cooperation also play a role. A 3 d food diary is the best method for a dietary assess-
ment, but it requires patient cooperation as well as patients being capable of writing 
and maintaining, which may be difficult in the mostly uneducated population of South 
Asia. Therefore, repeated short-term 24 h recalls are recommended and may prove to 
be important in this population[75,76]. Patients should at least be asked if their food 
intake has changed and by how much over what period of time.
In a study evaluating reasons for food aversion in a Pakistani population, it was 
concluded that factors such as advice from family doctor, close friends and relatives 
and alternative medicine practices influenced dietary restrictions in patients with 
advanced liver disease[77]. Lack of awareness about proper dietary intake was pre-
valent in both educated and uneducated populations with CLD in this population[78]. 
Table 2 summarizes the methods of nutritional assessment.
TREATMENT
General caloric and protein intake
A multidisciplinary approach for the treatment of malnutrition in liver cirrhosis is 
important for improving patient survival and long-term outcomes[79]. Nutritional 
counseling should be included in the patient management. According to the 2020 
European Society for Clinical Nutrition and Metabolism guidelines, patients of CLD 
and a sedentary lifestyle should consume a daily calorie intake of 1.3 × REE (Resting 
Energy Expenditure)[80], where indirect calorimetry has been used to calculate the 
REE.
Patients with cirrhosis are recommended to consume 3 to 5 meals per day ensuring 
there are short starvation periods in between. A late evening carbohydrate snack has 
been shown to improve protein metabolism in cirrhosis by affecting nitrogen balance
[81-83]. Patients should have an energy intake of 30-35 kcal/kg per day and a protein 
intake of 1.2-1.5 g/kg per day, whereas non-malnourished patients are recommended 
to intake 1.2g/kg per day of protein, and malnourished and sarcopenic patients 
should consume 1.5 g/kg per day of protein. However, a higher caloric intake is 
recommended for patients with acute decompensation or conditions with increased 
energy expenditure. REE should be calculated whenever possible[80]. In patients with 
HE, there is no recommendation for protein restriction[84-86].
Use of BCAA
In patients who are protein intolerant (develop HE with ingestion of mixed proteins), 
consumption of BCAA (at the rate of 0.25 g/kg per day) or vegetable derived proteins 
is recommended[80,87].
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Table 2 Nutritional assessment methods for chronic liver disease
Nutritional assessment methods Description
Subjective global assessment (SGA) Uses components of history and physical exam
Royal free hospital subjective global 
assessment (RFH-SGA)
Modified version of SGA, includes anthropometry and gender
Sarcopenia assessment
Computed tomography scan Used to calculate skeletal muscle area and the skeletal muscle index at the L3 vertebral level
Anthropometry Mid arm muscle circumference, skin fold thickness, BMI calculation
Dual-energy X-ray absorptiometry A radiological modality that is used to measure bone mass, fat mass and fat free mass
Bioelectrical impedance analysis Alternating current is used to estimate total body water, fat mass and fat free mass
Liver specific tools
Royal Free Hospital-Nutrition Prioritizing Tool Includes weight loss, volume overload, BMI, and reduced oral intake, classifies patients according to risk 
of malnutrition
Liver Disease Undernutrition Screening Tool 
(LDUST)
The LDUST includes components of oral intake, weight loss, loss of subcutaneous fat or muscle mass, 
volume overload, and functional status
Dietary assessment Includes dietary review, 3 d food diary, 24 h diet recall
BMI: Body mass index; SGA: Subjective global assessment.
Prescription of long-term BCAA supplement is recommended for patients with 
advance cirrhosis. Use of BCAA enriched formula has been shown to improve survival 
in patients with alcoholic steatohepatitis and cirrhosis with an improved mental state 
in protein intolerant cirrhotic patients with HE[6,88-91]. However, the cost of BCAA 
supplements needs to be considered when prescribing them to patients.
Micronutrients
In cirrhotic patients, any micronutrient deficiency should be corrected. Micronutrient 
deficiencies may include both water soluble (especially thiamine) and lipid soluble 
deficiencies[92,93]. While there are no proven therapeutic effects directly by correcting 
micronutrient deficiencies, supplementation of zinc and vitamin A may improve 
dysgeusia and hence nutritional intake and affect the nutritional status indirectly[93,
94]. While zinc deficiency has been associated with HE, supplementation has not 
shown any significant therapeutic effect on the encephalopathy[95-99]. Practically, a 
liberal supplementation is recommended in the first 2 wk of therapy, as a diagnosis of 
a deficiency would be costly and take time[80].
If a low sodium diet is prescribed in the scenario of ascites, the increased risk of 
lower intake should be considered due to the non-palatability of such a diet[100,101]. 
Ensuring adequate nutrition intake is important with sodium restriction.
Enteral and parenteral nutrition
If patients are unable to tolerate diet orally or if the nutritional target is unmet with 
oral nutrition, enteral nutrition (EN) is recommended. An adequate nutrient intake is 
the primary goal in cirrhotic patients. EN has been proven to be beneficial in survival 
and liver function[84,89]. However, with EN a risk of overfeeding exists, as the energy 
intake can exceed the recommended intake.
If the patient is unable to maintain oral and EN, parenteral nutrition (PN) should be 
used. When administering parenteral nutrition, patients are more prone to infection 
and sepsis through intravenous lines[25].
CONCLUSION
Malnutrition in liver cirrhosis is a serious problem in South Asia where the etiology 
differs from the Western population. As malnutrition is generally highly prevalent in 
the region, it causes an impact on patients with liver cirrhosis. Urgent attention to 
address malnutrition is needed to improve patient outcomes. Emphasis on assessment 
for nutritional status at the initial visit with recording of vital signs is needed. 
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Simultaneously, treating physicians need to be made aware of the misconceptions 
surrounding nutritional restrictions in cirrhosis so that patient education is done 
correctly based on proper scientific evidence.
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